159 related articles for article (PubMed ID: 33868993)
1. A Nomogram Combining a Four-Gene Biomarker and Clinical Factors for Predicting Survival of Melanoma.
Zhang C; Dang D; Wang Y; Cong X
Front Oncol; 2021; 11():593587. PubMed ID: 33868993
[TBL] [Abstract][Full Text] [Related]
2. Nomogram based on autophagy related genes for predicting the survival in melanoma.
Deng G; Wang W; Li Y; Sun H; Chen X; Zeng F
BMC Cancer; 2021 Nov; 21(1):1258. PubMed ID: 34809598
[TBL] [Abstract][Full Text] [Related]
3. A Novel Nomogram and Risk Classification System Predicting the Cancer-Specific Mortality of Patients with Initially Diagnosed Metastatic Cutaneous Melanoma.
Li W; Xiao Y; Xu X; Zhang Y
Ann Surg Oncol; 2021 Jul; 28(7):3490-3500. PubMed ID: 33191484
[TBL] [Abstract][Full Text] [Related]
4. Development and validation of a prognostic nomogram for colorectal cancer after surgery.
Li BW; Ma XY; Lai S; Sun X; Sun MJ; Chang B
World J Clin Cases; 2021 Jul; 9(21):5860-5872. PubMed ID: 34368305
[TBL] [Abstract][Full Text] [Related]
5. CXCR3 predicts the prognosis of endometrial adenocarcinoma.
Dong H; Sun M; Li H; Yue Y
BMC Med Genomics; 2023 Feb; 16(1):20. PubMed ID: 36750966
[TBL] [Abstract][Full Text] [Related]
6. A novel RNA sequencing-based prognostic nomogram to predict survival for patients with cutaneous melanoma: Clinical trial/experimental study.
Tian J; Yang Y; Li MY; Zhang Y
Medicine (Baltimore); 2020 Jan; 99(3):e18868. PubMed ID: 32011509
[TBL] [Abstract][Full Text] [Related]
7. Development and validation of prognostic nomogram in patients with nonmetastatic malignant melanoma: a SEER population-based study.
Xiao Y; Peng S; Hu Y; Zhang J; Cao X
Cancer Med; 2020 Nov; 9(22):8562-8570. PubMed ID: 32941704
[TBL] [Abstract][Full Text] [Related]
8. A 15-Gene Signature and Prognostic Nomogram for Predicting Overall Survival in Non-Distant Metastatic Oral Tongue Squamous Cell Carcinoma.
Liu M; Tong L; Liang B; Song X; Xie L; Peng H; Huang D
Front Oncol; 2021; 11():587548. PubMed ID: 33767977
[TBL] [Abstract][Full Text] [Related]
9. Development and validation of a novel nomogram for predicting the prognosis of patients with resected pancreatic adenocarcinoma.
Ren H; Wu CR; Aimaiti S; Wang CF
Oncol Lett; 2020 Jun; 19(6):4093-4105. PubMed ID: 32382348
[TBL] [Abstract][Full Text] [Related]
10. Establishment and validation of a nomogram for predicting immune-related prognostic features in trunk melanoma-specific death.
Chu Y; Hu S; Li S; Qi X
Ann Transl Med; 2022 Dec; 10(24):1371. PubMed ID: 36660695
[TBL] [Abstract][Full Text] [Related]
11. Identification of a novel immune-related prognostic signature associated with tumor microenvironment for breast cancer.
Ding S; Sun X; Zhu L; Li Y; Chen W; Shen K
Int Immunopharmacol; 2021 Nov; 100():108122. PubMed ID: 34536743
[TBL] [Abstract][Full Text] [Related]
12. A Nomogram Model to Predict Prognosis of Patients With Genitourinary Sarcoma.
Li L; Liang J; Song T; Yin S; Zeng J; Zhong Q; Feng X; Jia Z; Fan Y; Wang X; Lin T
Front Oncol; 2021; 11():656325. PubMed ID: 33937065
[TBL] [Abstract][Full Text] [Related]
13. A nomogram based on pretreatment CT radiomics features for predicting complete response to chemoradiotherapy in patients with esophageal squamous cell cancer.
Luo HS; Huang SF; Xu HY; Li XY; Wu SX; Wu DH
Radiat Oncol; 2020 Oct; 15(1):249. PubMed ID: 33121507
[TBL] [Abstract][Full Text] [Related]
14. Development and validation of nomogram combining serum biomarker for predicting survival in patients with resected rectal cancer.
Fan S; Li T; Zhou P; Peng Q; Zhu Y
Biosci Rep; 2019 Nov; 39(11):. PubMed ID: 31693739
[TBL] [Abstract][Full Text] [Related]
15. Nomogram for predicting the survival of patients with malignant melanoma: A population analysis.
Yang J; Pan Z; Zhou Q; Liu Q; Zhao F; Feng X; Lyu J
Oncol Lett; 2019 Oct; 18(4):3591-3598. PubMed ID: 31516573
[TBL] [Abstract][Full Text] [Related]
16. An integrated nomogram combining deep learning, Prostate Imaging-Reporting and Data System (PI-RADS) scoring, and clinical variables for identification of clinically significant prostate cancer on biparametric MRI: a retrospective multicentre study.
Hiremath A; Shiradkar R; Fu P; Mahran A; Rastinehad AR; Tewari A; Tirumani SH; Purysko A; Ponsky L; Madabhushi A
Lancet Digit Health; 2021 Jul; 3(7):e445-e454. PubMed ID: 34167765
[TBL] [Abstract][Full Text] [Related]
17. Construction of a novel mRNA-signature prediction model for prognosis of bladder cancer based on a statistical analysis.
Li J; Cao J; Li P; Yao Z; Deng R; Ying L; Tian J
BMC Cancer; 2021 Jul; 21(1):858. PubMed ID: 34315402
[TBL] [Abstract][Full Text] [Related]
18. Development and Validation of a Nomogram Prognostic Model for Patients With Advanced Non-Small-Cell Lung Cancer.
Wang T; Lu R; Lai S; Schiller JH; Zhou FL; Ci B; Wang S; Gao X; Yao B; Gerber DE; Johnson DH; Xiao G; Xie Y
Cancer Inform; 2019; 18():1176935119837547. PubMed ID: 31057324
[TBL] [Abstract][Full Text] [Related]
19. Predicting the Survival Probability of Neuroendocrine Tumor Populations: Developing and Evaluating a New Predictive Nomogram.
Chen JX; Lin Y; Meng YL; Zhao AX; Huang XJ; Liang R; Li YQ; Liu ZH
Biomed Res Int; 2021; 2021():9126351. PubMed ID: 33575356
[TBL] [Abstract][Full Text] [Related]
20. A novel immune checkpoint-related seven-gene signature for predicting prognosis and immunotherapy response in melanoma.
Tian M; Yang J; Han J; He J; Liao W
Int Immunopharmacol; 2020 Oct; 87():106821. PubMed ID: 32731180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
